All treatments
Treatment
UCB0599 PRD4385815 clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A DOSE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF UCB0599 IN STUDY PARTICIPANTS WITH PARKINSON’S DISEASE
This study is testing a new medicine, UCB0599, for Parkinson's disease. Researchers want to see if it's safe, how well it works long-term, and if it helps protect brain cells. They are comparing it to a dummy pill.
For: Parkinson’s diseaseNetherlands · Germany · Spain - Ongoing, recruitingHuman Pharmacology (Phase I)- Other
AN OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE THE RELATIVE BIOAVAILABILITY OF A NEW TABLET FORMULATION OF MINZASOLMIN AND THE POTENTIAL EFFECT OF FOOD ON THE PHARMACOKINETICS OF MINZASOLMIN IN HEALTHY PARTICIPANTS
This study looks at a new tablet version of a drug called Minzasolmin. We want to see how well the body absorbs it compared to an older form, and if food changes how it works. This is an early study in healthy people.
For: Healthy ParticipantsGermany